Mr. Damien McCallion:

We have been working with pharmacists for some time, and with the Irish Pharmacy Union, IPU, and the Pharmaceutical Society of Ireland, PSI. There are a number of steps that we had to go through with them. First, we had to reach an agreement. Second, we needed to put in place an operational framework as to how they would operate as vaccinators. Third, we needed to put in a technology solution that would allow them to function. We will have provided some of that information in the briefing note. We plan to trial that solution. It will be a cold trial. In other words, pharmacists will not actually be vaccinating people during the trial; they will just be trialling the system to make sure that it all functions properly.

The issue from there is partially supply-driven, so the point at when we take them on-----